Von Willebrand factor in patients evolving Q-wave versus non-Q-wave acute myocardial infarction

Area of Science:

• Cardiology
• Hematology
• Biochemistry

Background:

• Myocardial infarction (MI) is a leading cause of death.
• Q-wave MI and non-Q-wave MI represent different pathological entities.
• Biomarkers for MI severity and prognosis are crucial.

Purpose of the Study:

• To investigate plasma von Willebrand factor (vWF) levels in patients with Q-wave MI versus non-Q-wave MI.
• To assess changes in vWF concentration over time post-MI.
• To compare vWF levels with fibrinogen concentration.

Main Methods:

• Enzyme-linked immunoassay (ELISA) was used to measure vWF antigen levels.
• Plasma samples were collected twice daily for 4 days from patients with Q-wave MI (n=10) and non-Q-wave MI (n=6).
• Patients did not receive thrombolytic treatment.

Main Results:

• Patients with Q-wave MI showed a significant rise in vWF antigen levels (P < 0.05) post-admission, persisting for 3 days.
• No significant changes in plasma fibrinogen concentration were observed.
• Elevated vWF antigen levels were observed in Q-wave MI patients compared to non-Q-wave MI patients.

Conclusions:

• Plasma vWF antigen levels are significantly elevated in Q-wave myocardial infarction.
• vWF may serve as a differential biomarker between Q-wave and non-Q-wave MI.
• Further research into vWF's role in MI pathophysiology is warranted.